NASDAQ · Medical - Instruments & Supplies

STAAR Surgical Company (STAA) Stock

$21.67 -3.17% NASDAQ: STAA Healthcare

Valuation

MetricValue
Price$21.67
Market Cap$1.08B
P/E Ratio277.56
P/B Ratio3.06
P/S Ratio3.26
EPS (TTM)$0.77
52-Week High$35.87
52-Week Low$15.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE1.08%
ROA0.81%
ROCE8.73%
Gross Margin76.43%
Operating Margin-1.72%
Net Margin1.13%
Debt/Equity0.10
Current Ratio4.52

Annual Financials (USD)

Metric20212022202320242025
Revenue$230.0M$284.0M$322.0M$314.0M$239.0M
Operating Profit$33.0M$44.0M$28.0M$-13.0M$-46.0M
Net Profit$28.0M$40.0M$21.0M$-20.0M$-80.0M
EPS$0.50$0.80$0.43$-0.41$-1.62
Op Margin14.5%15.4%8.7%-4.0%-19.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$346.0M$419.0M$489.0M$510.0M$462.0M
Total Liabilities$87.0M$83.0M$103.0M$112.0M$117.0M
Cash$200.0M$86.0M$183.0M$144.0M$153.0M
Borrowings$32.0M$31.0M$36.0M$39.0M$38.0M

Latest News

STAA: Lowering target price to $21.00 Argus Research · Jul 22, 2026 STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know StockStory · Jul 17, 2026 3 Unprofitable Stocks with Questionable Fundamentals StockStory · Jul 17, 2026 Staar Surgical China Turnaround Continues to Boost Confidence, Wedbush Says MT Newswires · Jul 17, 2026 STAAR Surgical Reports Higher Q2 Preliminary Net Sales MT Newswires · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$44.0M$36.0M$15.0M$16.0M$-34.0M
Investing Cash Flow$-27.0M$-174.0M$56.0M$-83.0M$41.0M
Financing Cash Flow$19.0M$8.0M$8.0M$6.0M$-8.0M
Net Cash Flow$47.0M$-113.0M$97.0M$-39.0M$9.0M
Free Cash Flow$30.0M$18.0M$-4.0M$-8.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.81
EV / EBITDA30.98
FCF Yield-0.61%
Quick Ratio4.03
Interest Coverage0.00
Return 1Y25.40%
Return 3Y-58.09%
Return 5Y-78.79%

Ownership

Insiders Held0.78%
Institutions Held113.72%
Institutions Float Held114.62%
Institutional HolderSharesReport Date
Broadwood Capital, Inc.16,123,8422026-03-31
Blackrock Inc.6,666,1182026-03-31
Yunqi Capital Ltd3,257,1302026-03-31
Madison Avenue Partners, LP2,441,6782026-03-31
Vanguard Portfolio Management LLC2,123,5892026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALCAlcon Inc. $64.11 +1.55% 50.34 $31.27B 0.55%
BLCOBausch + Lomb Corporation $17.30 +0.87% -35.85 $6.18B 0.00%
COOThe Cooper Companies, Inc. $54.37 +0.13% 19.29 $10.60B 0.00%
RXSTRxSight, Inc. $4.81 -0.82% -4.14 $199.12M 0.00%

About STAAR Surgical Company

STAAR Surgical Company is led by CEO Warren Foust, employs 1,157 people, headquartered in US, publicly traded since 1992.

STAAR Surgical Company (STAA) stock trades at $21.67 with a market capitalization of $1.08B. The stock is valued at a price-to-earnings (P/E) ratio of 277.56, price-to-book of 3.06, price-to-sales of 3.26. Over the past 52 weeks the stock has ranged between $15.59 and $35.87, and currently trades 39.6% below its 52-week high.

On profitability, STAAR Surgical Company generates a return on equity (ROE) of 1.08%, return on capital employed of 8.73%, an operating margin of -1.72%, a net profit margin of 1.13%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides